Antiphospholipid Antibodies Modify the Prognostic Value of Baseline Platelet Count for Clinical Outcomes After Ischemic Stroke

• Published in: Journal of the American Heart Association Vol. 13; no. 19; p. e035183
• Main Authors: Wang, Yinan, Yang, Pinni, Zhu, Zhengbao, Peng, Hao, Bu, Xiaoqing, Xu, Qingyun, Wang, Aili, Chen, Jing, Xu, Tan, Zhang, Yonghong, He, Jiang
• Format: Journal Article
• Language: English
• Published: England John Wiley and Sons Inc 01.10.2024; Wiley
• Subjects: Aged; Antibodies, Antiphospholipid - blood; antiphospholipid antibodies; Biomarkers - blood; Blood Platelets - immunology; Female; Humans; ischemic stroke; Ischemic Stroke - blood; Ischemic Stroke - diagnosis; Ischemic Stroke - immunology; Male; Middle Aged; Original Research; Platelet Count; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Time Factors; platelet count; prognosis; antiphospholipid antibodies; ischemic stroke

Antiphospholipid antibodies (aPLs) have been reported to be involved in platelet-mediated thrombosis and inflammation, but the impact on the prognosis of ischemic stroke remains unclear. We aimed to examine whether the association between baseline platelet count (PLT) and long-term clinical outcomes...